Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 2
This trial was for people with chronic lymphocytic leukaemia (CLL) who had a high risk of their leukaemia coming back.
Cancer Research UK supported this trial.
Recruitment start: 6 February 2012
Recruitment end: 31 October 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof A Pettitt
Baxter Ltd
Cancer Research UK
Cancer Research UK Liverpool Cancer Trials Unit (LCTU)
Celgene Ltd
Chugai Pharmaceutical Co Ltd
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Royal Liverpool and Broadgreen University Hospital NHS Trust
University of Liverpool
This is Cancer Research UK trial number CRUKE/09/035.
Last reviewed: 20 Sept 2017
CRUK internal database number: 3492